Noblis ESI to provide support services for the Joint Enterprise-Research Development Acquisition Program
CHANTILLY, Va. (PRWEB) March 01, 2018
"Noblis ESI is proud to have the opportunity to expand our footprint in CBRN through this award, which further diversifies our unwavering support of the defense mission," said Vernon Ingram, President of Noblis ESI. "We look forward to delivering integrated capabilities, along with our team members, that will better enable the warfighter to remain secure and connected regardless of the operational environment"
With this award, Noblis will provide subject matter experts, capabilities, and contextual experience to support research, development, production, procurement, and fielding of Chemical, Biological, Radiological, and Nuclear (CBRN) defense systems, equipment, and materiel for the Department of Defense.
"The Noblis family of companies provides a wide spectrum of support to the chemical and biological defense mission- from medical countermeasures, to bioinformatics tools, to detection analysis," said Jordin Cohen, Noblis Vice President of Defense and Homeland Security. "Noblis has supported JPEO-CBD since 2009, and we look forward to continuing to ensure that our nation's warfighters remain capable and protected during all conditions."
###
About Noblis ESI
Noblis ESI is a wholly owned subsidiary of Noblis Inc., a nonprofit science, technology, and strategy organization. Noblis ESI specializes in providing the DoD and Intelligence Community with innovative engineering and technical solutions in C4ISR systems.
For the original version on PRWeb visit: http://www.prweb.com/releases/2018/03/prweb15270262.htm
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
